Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma
- 30 June 2000
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 94, S35-S41
- https://doi.org/10.1016/s0954-6111(00)80148-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthmaRespiratory Medicine, 2000
- Pharmaceutical transition to non-CFC pressurized metered dose inhalersRespiratory Medicine, 2000
- Dose proportionality of fluticasone propionate from hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIsRespiratory Medicine, 2000
- Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Practical issues in equivalence trialsStatistics in Medicine, 1998
- Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yrRespiratory Medicine, 1996
- Assessing equivalence of inhaled drugsRespiratory Medicine, 1995
- Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthmaJournal of Allergy and Clinical Immunology, 1994
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- Paradoxical Bronchospasm After Use of Inhalation Aerosols: A Review of the LiteratureJournal of Asthma, 1991